162 related articles for article (PubMed ID: 37898039)
1. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
2. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
[TBL] [Abstract][Full Text] [Related]
3. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.
Almangush A; Leivo I; Mäkitie AA
Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615
[No Abstract] [Full Text] [Related]
4. Tumor infiltrating lymphocytes in head and neck squamous cell carcinoma - Evaluation and clinical impact.
Dasgupta S; Chakrabarti S; Deb AR
J Cancer Res Ther; 2022; 18(1):49-54. PubMed ID: 35381761
[TBL] [Abstract][Full Text] [Related]
5. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685
[TBL] [Abstract][Full Text] [Related]
6. Role Of Cd8+ Tumour-Infiltrating Lymphocytes In Predicting Regional Lymph Node Metastasis In Lip And Oral Cavity Squamous Cell Carcinoma.
Sukhera ZA; Zafar N; Ara N; Muneer S; Haroon A; Saeed Z
J Ayub Med Coll Abbottabad; 2023; 35(2):288-293. PubMed ID: 37422823
[TBL] [Abstract][Full Text] [Related]
7. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L
Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516
[TBL] [Abstract][Full Text] [Related]
8. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB
Adv Anat Pathol; 2017 Nov; 24(6):311-335. PubMed ID: 28777143
[TBL] [Abstract][Full Text] [Related]
9. Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.
Almangush A; Jouhi L; Atula T; Haglund C; Mäkitie AA; Hagström J; Leivo I
Br J Cancer; 2022 Jun; 126(11):1589-1594. PubMed ID: 35043007
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer.
Heikkinen I; Bello IO; Wahab A; Hagström J; Haglund C; Coletta RD; Nieminen P; Mäkitie AA; Salo T; Leivo I; Almangush A
Am J Surg Pathol; 2019 Oct; 43(10):1392-1396. PubMed ID: 31290758
[TBL] [Abstract][Full Text] [Related]
11. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome.
Mohammadi Y; Ahmadvand S; Mirtalebi M; Ashraf MJ; Khademi B; Ghaderi A
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S133-S142. PubMed ID: 36319566
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and clinicopathological status of PD-L1 expression and CD8+ TILs in oral squamous cell cancer patients with or without traditional risk factors.
Soopanit T; Laokulrath N; Chayopasakul V; Pongsapich W
Head Neck; 2023 Apr; 45(4):1017-1025. PubMed ID: 36811208
[TBL] [Abstract][Full Text] [Related]
13. Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma.
Kligerman MP; Moon PK; Tusty M; Cloutier JM; Ma Y; Holsinger CF; Divi V
Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):731-737. PubMed ID: 35899590
[TBL] [Abstract][Full Text] [Related]
14. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating ICOS
Kajikawa H; Hirata M; Haruna M; Ueyama A; Hirose K; Kawashima A; Iwahori K; Matsunaga K; Toyosawa S; Uzawa N; Wada H
Anticancer Res; 2022 May; 42(5):2383-2393. PubMed ID: 35489733
[TBL] [Abstract][Full Text] [Related]
16. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
17. A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.
Shaban M; Khurram SA; Fraz MM; Alsubaie N; Masood I; Mushtaq S; Hassan M; Loya A; Rajpoot NM
Sci Rep; 2019 Sep; 9(1):13341. PubMed ID: 31527658
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis.
Wahbi HS; Manadili A
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4177-4183. PubMed ID: 36580000
[TBL] [Abstract][Full Text] [Related]
19. TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?
De Meulenaere A; Vermassen T; Aspeslagh S; Vandecasteele K; Rottey S; Ferdinande L
Head Neck Pathol; 2017 Sep; 11(3):354-363. PubMed ID: 28032290
[TBL] [Abstract][Full Text] [Related]
20. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
